Intercellular communication, three-dimensional cell contact and radiosensitivity.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 7150703)

Published in Biophys Struct Mech on January 01, 1982

Authors

H Dertinger, G Hinz, K H Jakobs

Articles by these authors

(truncated to the top 100)

Botulinum C2 toxin ADP-ribosylates actin. Nature (1986) 3.16

Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur J Biochem (1985) 3.04

Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet (1998) 2.98

A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nat Cell Biol (2001) 2.45

Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat Res (1984) 2.06

Transport of storage proteins to the vacuole is mediated by vesicles without a clathrin coat. J Cell Sci (1996) 1.94

Energy dependence of protein translocation into chloroplasts. Eur J Biochem (1986) 1.92

Protein storage vacuoles form de novo during pea cotyledon development. J Cell Sci (1995) 1.65

Activation of a high affinity Gi protein-coupled plasma membrane receptor by sphingosine-1-phosphate. J Biol Chem (1996) 1.56

Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine. J Cyclic Nucleotide Res (1977) 1.54

Vacuolar storage proteins are sorted in the cis-cisternae of the pea cotyledon Golgi apparatus. J Cell Biol (2001) 1.46

Stimulation of phospholipase C by guanine-nucleotide-binding protein beta gamma subunits. Eur J Biochem (1992) 1.43

Sphingosine kinase-mediated Ca2+ signalling by G-protein-coupled receptors. EMBO J (1998) 1.41

Modulation of adenylate cyclase of human platelets by phorbol ester. Impairment of the hormone-sensitive inhibitory pathway. Eur J Biochem (1985) 1.39

Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. Circulation (1990) 1.36

Uncoupling of alpha-adrenoceptor-mediated inhibition of human platelet adenylate cyclase by N-ethylmaleimide. J Biol Chem (1982) 1.32

Molecular diversity of sphingolipid signalling. FEBS Lett (1997) 1.31

Demonstration of cGMP-dependent protein kinase and cGMP-dependent phosphorylation in cell-free extracts of platelets. Eur J Biochem (1986) 1.31

Angiotensin II and alpha-adrenergic agonists inhibit rat liver adenylate cyclase. J Biol Chem (1981) 1.31

The molecular characterization of transport vesicles. Plant Mol Biol (1998) 1.30

Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11. Mol Pharmacol (1994) 1.30

Regulation of muscarinic acetylcholine receptor sequestration and function by beta-arrestin. J Biol Chem (1999) 1.29

Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein alpha-subunits. Eur J Pharmacol (1989) 1.26

Two distinct Gi-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells. J Biol Chem (1989) 1.23

Activation of muscarinic K+ current in guinea-pig atrial myocytes by sphingosine-1-phosphate. J Physiol (1995) 1.22

Ni-mediated inhibition of human platelet adenylate cyclase by thrombin. Eur J Biochem (1984) 1.18

Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br J Pharmacol (2000) 1.16

A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells. Nature (1983) 1.13

GTP-dependent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agonists. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.12

Sphingosine kinase-mediated calcium signaling by muscarinic acetylcholine receptors. Life Sci (2001) 1.11

Epinephrine inhibits adenylate cyclase and stimulates a GTPase in human platelet membranes via alpha-adrenoceptors. FEBS Lett (1981) 1.11

Purification and immunochemical characterization of the major pertussis-toxin-sensitive guanine-nucleotide-binding protein of bovine-neutrophil membranes. Eur J Biochem (1987) 1.11

Phospholipase D stimulation by receptor tyrosine kinases mediated by protein kinase C and a Ras/Ral signaling cascade. J Biol Chem (1999) 1.10

Muscarinic acetylcholine receptor-stimulated binding of guanosine 5'-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. Eur J Biochem (1989) 1.09

Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms. J Clin Invest (1985) 1.08

ADP-ribosylation of platelet actin by botulinum C2 toxin. Eur J Biochem (1986) 1.08

Measurement of receptor-stimulated guanosine 5'-O-(gamma-thio)triphosphate binding by G proteins. Methods Enzymol (1994) 1.07

Kinetic response of an in vitro "tumour-model" (V 79 spheroids) to 42 degrees C hyperthermia. Eur J Cancer (1977) 1.05

Receptor subtype-specific regulation of muscarinic acetylcholine receptor sequestration by dynamin. Distinct sequestration of m2 receptors. J Biol Chem (1998) 1.04

Evidence for two GTPases activated by thrombin in membranes of human platelets. Biochem J (1986) 1.03

Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. Br J Pharmacol (2000) 1.03

Evidence for Edg-3 receptor-mediated activation of I(K.ACh) by sphingosine-1-phosphate in human atrial cardiomyocytes. Mol Pharmacol (2000) 1.03

Rho-specific binding and guanine nucleotide exchange catalysis by KIAA0380, a dbl family member. FEBS Lett (1999) 1.03

Inhibition of adenylate cyclase by hormones and neurotransmitters. Adv Cyclic Nucleotide Res (1981) 1.02

Inhibition of adenylate cyclase. Adv Cyclic Nucleotide Protein Phosphorylation Res (1985) 1.02

The role of nucleoside-diphosphate kinase reactions in G protein activation of NADPH oxidase by guanine and adenine nucleotides. Eur J Biochem (1988) 1.01

Calcium signalling by G protein-coupled sphingolipid receptors in bovine aortic endothelial cells. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.99

Inhibition of adenylate cyclase by hormones and neurotransmitters. Mol Cell Endocrinol (1979) 0.99

ADP receptor induced activation of guanine nucleotide binding proteins in rat platelet membranes--an effect selectively blocked by the thienopyridine clopidogrel. Thromb Haemost (1992) 0.99

Identification and characterization of a novel Rho-specific guanine nucleotide exchange factor. Biochem J (2000) 0.99

Regulation of adenylate cyclase activity in hamster adipocytes. Inhibition by prostaglandins, alpha-adrenergic agonists and nicotinic acid. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.99

Mechanism of pertussis toxin action on the adenylate cyclase system. Inhibition of the turn-on reaction of the inhibitory regulatory site. Eur J Biochem (1984) 0.99

Stimulation of phosphatidylinositol-4-phosphate 5-kinase by Rho-kinase. J Biol Chem (2000) 0.99

Formyl peptide receptor signaling in HL-60 cells through sphingosine kinase. J Biol Chem (1999) 0.98

Regulation of signal transfer from beta 1-adrenoceptor to adenylate cyclase by beta gamma subunits in a reconstituted system. Eur J Biochem (1987) 0.98

Interactions of forskolin and adenylate cyclase. Effects on substrate kinetics and protection against inactivation by heat and N-ethylmaleimide. J Biol Chem (1983) 0.98

Inhibition of receptor signaling to phospholipase D by Clostridium difficile toxin B. Role of Rho proteins. J Biol Chem (1996) 0.98

The M3 muscarinic acetylcholine receptor expressed in HEK-293 cells signals to phospholipase D via G12 but not Gq-type G proteins: regulators of G proteins as tools to dissect pertussis toxin-resistant G proteins in receptor-effector coupling. J Biol Chem (2000) 0.97

Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest (1995) 0.97

Role of sphingosine kinase in Ca(2+) signalling by epidermal growth factor receptor. FEBS Lett (1999) 0.97

Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors. Eur J Pharmacol (2001) 0.97

Depolarisation induces rapid and transient formation of intracellular sphingosine-1-phosphate. FEBS Lett (2001) 0.97

Guanine nucleotide-specific phosphate transfer by guanine nucleotide-binding regulatory protein beta-subunits. Characterization of the phosphorylated amino acid. J Biol Chem (1993) 0.97

Characterization of alpha- and beta-adrenergic receptors linked to human platelet adenylate cyclase. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.97

Signal amplification in HL-60 granulocytes. Evidence that the chemotactic peptide receptor catalytically activates guanine-nucleotide-binding regulatory proteins in native plasma membranes. Eur J Biochem (1991) 0.96

Essential role of dynamin in internalization of M2 muscarinic acetylcholine and angiotensin AT1A receptors. J Biol Chem (2000) 0.95

Activation of calcium currents in cardiac myocytes by empty beta-adrenoceptors. Circulation (1993) 0.95

Quantification of NGF-dependent neuronal differentiation of PC-12 cells by means of neurofilament-L mRNA expression and neuronal outgrowth. J Neurosci Methods (2004) 0.95

Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes. Eur J Pharmacol (1992) 0.95

A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils. Mol Pharmacol (1996) 0.95

Occurrence of an inhibitory guanine nucleotide-binding regulatory component of the adenylate cyclase system in cyc- variants of S49 lymphoma cells. Eur J Biochem (1983) 0.95

Localization of pyrophosphatase in membranes of cauliflower inflorescence cells. Planta (1999) 0.94

Molecular forms and subunit structure of the acetylcholine receptor in the central nervous system of insects. J Neurosci (1985) 0.94

Inhibition of platelet adenylate cyclase by epinephrine requires GTP. FEBS Lett (1978) 0.94

A role for rho-kinase in rho-controlled phospholipase D stimulation by the m3 muscarinic acetylcholine receptor. J Biol Chem (1999) 0.94

Control of cellular phosphatidylinositol 4,5-bisphosphate levels by adhesion signals and rho GTPases in NIH 3T3 fibroblasts involvement of both phosphatidylinositol-4-phosphate 5-kinase and phospholipase C. Eur J Biochem (2000) 0.94

Receptor-mediated ADP-ribosylation of a phospholipase C-stimulating G protein. FEBS Lett (1987) 0.93

Mechanisms and components involved in adenylate cyclase inhibition by hormones. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 0.93

Activation of signal-transducing guanine-nucleotide-binding regulatory proteins by guanosine 5'-[gamma-thio]triphosphate. Information transfer by intermediately thiophosphorylated beta gamma subunits. Eur J Biochem (1991) 0.93

Stimulation of a low Km GTPase by inhibitors of adipocyte adenylate cyclase. Mol Pharmacol (1982) 0.92

G protein specificity in receptor-effector coupling. Analysis of the roles of G0 and Gi2 in GH4C1 pituitary cells. J Biol Chem (1994) 0.92

Stimulation of cAMP synthesis by Gi-coupled receptors upon ablation of distinct Galphai protein expression. Gi subtype specificity of the 5-HT1A receptor. J Biol Chem (1999) 0.92

Occurrence of a hormone-sensitive inhibitory coupling component of the adenylate cyclase in S49 lymphoma cyc- variants. Proc Natl Acad Sci U S A (1983) 0.92

A role for Rho in receptor- and G protein-stimulated phospholipase C. Reduction in phosphatidylinositol 4,5-bisphosphate by Clostridium difficile toxin B. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.91

Increased radioresistance of cells in cultured multicell spheroids. I. Dependence on cellular interaction. Radiat Environ Biophys (1981) 0.91

Discrimination between plasma membrane and intracellular target sites of sphingosylphosphorylcholine. Eur J Pharmacol (1998) 0.91

Stimulation and inhibition of human platelet membrane high-affinity GTPase by neomycin. FEBS Lett (1988) 0.91

Guanosine 5'-[gamma-thio]triphosphate-stimulated hydrolysis of phosphatidylinositol 4,5-bisphosphate in HL-60 granulocytes. Evidence that the guanine nucleotide acts by relieving phospholipase C from an inhibitory constraint. Biochem J (1990) 0.90

Evidence for ADP-ribosylation-factor-mediated activation of phospholipase D by m3 muscarinic acetylcholine receptor. Eur J Biochem (1995) 0.90

A comparative study of post-irradiation growth kinetics of spheroids and monolayers. Int J Radiat Biol Relat Stud Phys Chem Med (1975) 0.89

Receptor-regulated formation of GTP[gamma S] with subsequent persistent Gs-protein activation in membranes of human platelets. FEBS Lett (1989) 0.89

Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats. Br J Pharmacol (2001) 0.89

Desensitization uncouples the formyl peptide receptor-guanine nucleotide-binding protein interaction in HL60 cells. Mol Pharmacol (1989) 0.89

Dual Mg2+ control of formyl-peptide-receptor--G-protein interaction in HL 60 cells. Evidence that the low-agonist-affinity receptor interacts with and activates the G-protein. Eur J Biochem (1989) 0.89

Different inhibitory effect of adrenaline on platelet adenylate cyclase in the presence of GTP plus cholera toxin and of stable GTP analogues. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.89

Mechanisms of phospholipase D stimulation by m3 muscarinic acetylcholine receptors. Evidence for involvement of tyrosine phosphorylation. Eur J Biochem (1994) 0.89

Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordellii lethal toxin and Clostridium difficile toxin B-1470 in HEK-293 cells. Restoration by Ral GTPases. J Biol Chem (1998) 0.89

Inhibition of NS-protein-stimulated human-platelet adenylate cyclase by epinephrine and stable GTP analogs. Eur J Biochem (1983) 0.89

Identification of G protein-coupled receptors potently stimulating migration of human transitional-cell carcinoma cells. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.89

m3 Muscarinic receptor-induced and Gi-mediated heterologous potentiation of phospholipase C stimulation: role of phosphoinositide synthesis. Mol Pharmacol (1996) 0.89